• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [1526 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening, diagnostics and indication for occupational therapy in children and adolescents with Developmental Coordination Disorders]
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hepatitis C virus screening in hospitals]
2016 Institute of Health Economics (IHE) Newborn blood spot screening for galactosemia, tyrosiemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease and severe combined immunodeficiency
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Use of anti-neuronal antibodies to diagnose paraneoplastic neurological syndromes
2016 Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment
2016 Health Quality Ontario (HQO) Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation
2016 HAYES, Inc. Oncotype DX DCIS Breast Cancer Test (Genomic Health Inc.)
2016 HAYES, Inc. Oncotype DX DCIS breast cancer test (Genomic Health Inc.)
2016 HAYES, Inc. Oncotype DX Genomic Prostate Score (GPS) Assay (Genomic Health Inc.)
2016 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Re-orientation of the Austrian parent-child preventive care programme. Part XII: Economic evaluation of selected screenings during pregnancy]
2016 Penn Medicine Center for Evidence-based Practice (CEP) Social work support following distress screening in oncology care
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, security and economic evaluation of the screening for cryptorchidism
2016 Basque Office for Health Technology Assessment (OSTEBA) [Design and validation of a screening tool for evaluating the health impact of regional policies]
2016 Basque Office for Health Technology Assessment (OSTEBA) [Impact of the implementation of a population-based cervical cancer screening program based on European recommendations (test/interval) with regard to the current situation]
2016 Basque Office for Health Technology Assessment (OSTEBA) [Prenatal screening for Down syndrome through fetal DNA sequencing from maternal blood]
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, security and economic evaluation of existing alternatives for monitoring growth and pubertal development
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, security and economic evaluation of existing alternatives for the early detection of hypercholesterolemia in the paediatric population.
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of existing alternatives for the early detection of childhood hearing impairment
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of existing alternatives for the early detection of arterial hypertension in paediatric population
2016 Health Sciences Institute in Aragon (IACS) Early detection program of health problems between the 0 and 14 years. Effectiveness, Safety and Economic Evaluation of the different existent alternatives in the early detection of alterations of psychomotor development
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of the existing alternatives for the early detection of Attention Deficit Hyperactivity Disorder (ADHD)
2016 Health Sciences Institute in Aragon (IACS) Early detection program of health problems between the 0 and 14 years. Effectivenes, safety and economic evaluation of the different existent alternatives in the early detection of autism spectrum disorders (ASD)
2016 Health Sciences Institute in Aragon (IACS) Effectiveness, safety and economic evaluation of existing alternatives for the early detection of visual impairment in the paediatric population.
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Parent information on newborn screening using pulse oximetry; addendum to commission S13-01]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for tyrosinaemia type 1 using tandem mass spectrometry]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information for health insurance fund members on ultrasound screening for abdominal aortic aneurysms: addendum to commission S13-04]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods - Addendum to Commission S13-02]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and decision aid for bowel cancer screening]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for severe combined immunodeficiency (SCID screening)]
2016 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Ataluren (expiry of the deadline)]
2016 Canary Health Service [Fetal DNA analysis in maternal blood for the detection of trisomies 21, 18 and 13]
2016 Canary Health Service [Safety, clinical effectiveness and cost-effectiveness of stereo-electroencephalography in epilepsy surgery]
2015 NIHR Health Technology Assessment programme The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2015 NIHR Health Technology Assessment programme Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
2015 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interventions to improve health-related behaviours of men]
2015 NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis
2015 NIHR Health Technology Assessment programme Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2015 NIHR Health Technology Assessment programme Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
2015 NIHR Health Technology Assessment programme The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2015 NIHR Health Services and Delivery Research programme Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015 Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in children ages 6 to 24 months: a systematic review to update the U.S. Preventive Services Task Force Recommendation
2015 Health Council of the Netherlands Gezondheidsraad (GR) Checking checked: appropriate use of health checks
2015 Health Council of the Netherlands Gezondheidsraad (GR) Neonatal screening: new recommendations
2015 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2015 Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2015 Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015 Health Quality Ontario (HQO) Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015 Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015 Belgian Health Care Knowledge Centre (KCE) Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening
2015 Belgian Health Care Knowledge Centre (KCE) Cardiovascular pre-participation screening in young athletes
2015 Belgian Health Care Knowledge Centre (KCE) What are the recommended clinical assessment and screening tests during pregnancy?
2015 Belgian Health Care Knowledge Centre (KCE) Oncogenetic testing for persons with hereditary endocrine cancer syndromes
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Panel antibody detection for idiopathic inflammatory myopathies]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Assessment on nucleic acid amplification techniques (NAT) for human immunodeficiency, hepatitis C and hepatitis B virus screening in blood banks]
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: β-ketothiolase deficiency (BKT); 3-hydroxy-3-methyl glutaric aciduria (HMG)]
2015 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015 Health Quality Ontario (HQO) Colon capsule endoscopy for the detection of colorectal polyps: OHTAC Recommendation
2015 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: risk stratification based on familial risk of bowel cancer
2015 Health Council of the Netherlands Gezondheidsraad (GR) [Population Screening Act: prevalence of gastrointestinal tract disorders studied with a video capsule]
2015 Agency for Healthcare Research and Quality (AHRQ) Screening for speech and language delays and disorders in children age 5 years or younger: a systematic review for the U.S. Preventive Services Task Force
2015 HAYES, Inc. Digital breast tomosynthesis for breast cancer diagnosis and screening
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Vitamin D screening in adults]
2015 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015 HAYES, Inc. Full-field digital mammography for breast cancer screening
2015 Haute Autorite de sante (HAS) [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]
2015 Haute Autorite de sante (HAS) [Modification of the nomenclature of procedures in laboratory medicine for research into Treponema pallidum (bacteria responsible for syphilis)]
2015 Malaysian Health Technology Assessment (MaHTAS) Capsule endoscopy for colorectal cancer (CRC) screening
2015 NIHR Horizon Scanning Centre (NIHR HSC) Rapid Rhythm ECG for atrial fibrillation
2015 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Opportunities and strategies to drive appropriate use of MRI in Austria. Part 2]
2015 Andalusian Health Technology Assessment Area (AETSA) Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2015 Adelaide Health Technology Assessment (AHTA) National Evidence-Based Guideline on Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes: Technical Report
2015 Adelaide Health Technology Assessment (AHTA) Screening for coronary artery disease using CT calcium scoring
2015 Adelaide Health Technology Assessment (AHTA) Blood and stool biomarker testing for colorectal cancer screening
2015 Adelaide Health Technology Assessment (AHTA) Circulating tumour DNA assays
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Newborn screening for critical congenital heart disease using pulse oximetry]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and fact sheet for breast cancer Screening - Rapid report]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound screening for abdominal aortic aneurysms]
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for visual impairment in children younger than 6 years - rapid report]
2015 Canary Health Service [Cost-effectiveness of neonatal screening for 3-hydroxy-3-methylglutaric aciduria (HMG)]
2015 Canary Health Service [Effectiveness, safety and cost-effectiveness of cholecystectomy versus conservative treatment for uncomplicated symptomatic cholelithiasis or acute cholecystitis]
2014 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2014 NIHR Health Technology Assessment programme A modelled analysis using data from the ARTISTIC trial of the potential effectiveness and cost-effectiveness of HPV testing in cervical cancer screening
2014 NIHR Health Technology Assessment programme Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2014 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2014 Agency for Healthcare Research and Quality (AHRQ) Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014 HAYES, Inc. PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)
2014 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014 Agency for Healthcare Research and Quality (AHRQ) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: systematic review to update the U.S. preventive services task force recommendation
2014 NIHR Horizon Scanning Centre (NIHR HSC) BreathLink™ for breast cancer screening
2014 Health Quality Ontario (HQO) Preoperative resting echocardiography for noncardiac surgery
2014 Health Quality Ontario (HQO) Preoperative cardiac stress tests for noncardiac surgery
2014 Health Quality Ontario (HQO) Preoperative consultations
2014 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Population-based colorectal cancer screening: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vancomycin-resistant enterococci isolation and screening strategies: clinical evidence and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-invasive prenatal testing: a review of the cost effectiveness and guidelines
2014 Blue Cross Blue Shield Association (BCBS) Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis